Kim SJ - Search Results

1

Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.

Grady WM, Myeroff LL, Swinler SE, Rajput A, Thiagalingam S, Lutterbaugh JD, Neumann A, Brattain MG, Chang J, Kim SJ, Kinzler KW, Vogelstein B, Willson JK, Markowitz S. Grady WM, et al. Among authors: kim sj. Cancer Res. 1999 Jan 15;59(2):320-4. Cancer Res. 1999. PMID: 9927040

2

Effect of ets-related transcription factor (ERT) on transforming growth factor (TGF)-beta type II receptor gene expression in human cancer cell lines.

Lee HJ, Chang JH, Kim YS, Kim SJ, Yang HK. Lee HJ, et al. Among authors: kim sj, kim ys. J Exp Clin Cancer Res. 2003 Sep;22(3):477-80. J Exp Clin Cancer Res. 2003. PMID: 14582709

3

A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability.

Myeroff LL, Parsons R, Kim SJ, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J, Park K, et al. Myeroff LL, et al. Among authors: kim sj. Cancer Res. 1995 Dec 1;55(23):5545-7. Cancer Res. 1995. PMID: 7585631

4

Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis.

Kim SJ, Im YH, Markowitz SD, Bang YJ. Kim SJ, et al. Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):159-68. doi: 10.1016/s1359-6101(99)00039-8. Cytokine Growth Factor Rev. 2000. PMID: 10708963 Review.

5

Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription factor, induces endogenous TGF-beta type II receptor expression and restores the TGF-beta signaling pathway in Hs578t human breast cancer cells.

Chang J, Lee C, Hahm KB, Yi Y, Choi SG, Kim SJ. Chang J, et al. Among authors: kim sj. Oncogene. 2000 Jan 6;19(1):151-4. doi: 10.1038/sj.onc.1203252. Oncogene. 2000. PMID: 10644990

6

MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.

Lee BI, Park SH, Kim JW, Sausville EA, Kim HT, Nakanishi O, Trepel JB, Kim SJ. Lee BI, et al. Among authors: kim sj, kim ht, kim jw. Cancer Res. 2001 Feb 1;61(3):931-4. Cancer Res. 2001. PMID: 11221885

7

Heterozygous mice for the transforming growth factor-beta type II receptor gene have increased susceptibility to hepatocellular carcinogenesis.

Im YH, Kim HT, Kim IY, Factor VM, Hahm KB, Anzano M, Jang JJ, Flanders K, Haines DC, Thorgeirsson SS, Sizeland A, Kim SJ. Im YH, et al. Among authors: kim iy, kim sj, kim ht. Cancer Res. 2001 Sep 15;61(18):6665-8. Cancer Res. 2001. PMID: 11559531

8

Genetic integrity of transforming growth factor beta (TGF-beta) receptors in cervical carcinoma cell lines: loss of growth sensitivity but conserved transcriptional response to TGF-beta.

Kang SH, Won K, Chung HW, Jong HS, Song YS, Kim SJ, Bang YJ, Kim NK. Kang SH, et al. Among authors: kim sj, kim nk. Int J Cancer. 1998 Aug 12;77(4):620-5. doi: 10.1002/(sici)1097-0215(19980812)77:4<620::aid-ijc23>3.0.co;2-8. Int J Cancer. 1998. PMID: 9679767 Free article.

9

Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease.

Hahm KB, Im YH, Parks TW, Park SH, Markowitz S, Jung HY, Green J, Kim SJ. Hahm KB, et al. Among authors: kim sj. Gut. 2001 Aug;49(2):190-8. doi: 10.1136/gut.49.2.190. Gut. 2001. PMID: 11454793 Free PMC article.

10

EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene.

Im YH, Kim HT, Lee C, Poulin D, Welford S, Sorensen PH, Denny CT, Kim SJ. Im YH, et al. Among authors: kim sj, kim ht. Cancer Res. 2000 Mar 15;60(6):1536-40. Cancer Res. 2000. PMID: 10749119

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13,887 results

Search Page